Accounting for Vaccines

Accounting for Vaccines

The AICPA’s Healthcare Expert Panel has issued a Technical Q&A regarding the accounting for vaccines that were provided during the pandemic. The guidance applies to nonprofits and for profit entities. The TQA requires entities to evaluate whether the transaction is exchange or nonexchange and if nonexchange whether the entity is acting as a principal or an agent.

PEEC Delays and Exposure Draft

PEEC Delays and Exposure Draft

The AICPA’s Professional Ethics Executive Committee (PEEC) delayed 3 interpretations at its May meeting. In addition, it has issued an exposure draft addressing record requests and updates the interpretation regarding acts discreditable. Comments are due September 30th.

Peer Review Provides COVID Delays

Peer Review Provides COVID Delays

This week the Peer Review Board of the AICPA voted to grant a six-month extensions for peer reviews, corrective actions, and implementation plans that had original due dates between January 1 and September 30, 2020. The delays, consistent with other standard setters, are trying to assist firms who are struggling with COVID19. As firms assist clients with obtaining assistance and work to audit in a remote environment, the delay is to provide relief. The additional six months is optional and if a firm and the reviewer are ready and able, they can continue as scheduled. The extension is automatic and does not have to be requested.

FASB Effective Date Delays for Certain Entities

FASB Effective Date Delays for Certain Entities

FASB has proposed a one year delay of revenue recognition for private company franchisors. In addition, public and nonpublic nonprofits will receive a delay along with nonpublic entities. The delay is due to the operational issues associated with COVID19. Originally, nonprofits with conduit debt were scheduled to adopt leases with public business entities but have now been granted a one year delay as many of these entities are hospitals and universities who are most impacted by COVID19.

X